The Osaka-based chemical manufacturer reported a steady 1.9% increase in revenue, reaching ¥61.37 billion for the period ending December 31. While top-line growth remained modest, the company’s operating profit surged to ¥1.83 billion, a significant jump from the ¥1.01 billion recorded during the same period the previous year. This divergence between core operating strength and the final bottom line highlights a complex fiscal landscape for the specialty chemicals firm.
Divergent Earnings Metrics
According to the company's latest financial filing, pretax profit also saw a substantial year-on-year improvement, rising to ¥1.67 billion from ¥945 million. However, the consolidated net profit failed to keep pace with the prior year's performance of ¥2.27 billion, suggesting that non-operating factors or specific tax adjustments weighed on the final results.Key financial indicators for the nine-month period include:
- Total revenue growth to ¥61.37 billion from ¥60.21 billion.
- Operating profit expansion of approximately 81%.
- Earnings per share (EPS) of ¥67.09, down from ¥114.32 a year earlier.




Comments (0)
No comments yet. Be the first!